Quantcast
Home / News / Risperdal maker hit with $1.1 billion verdict

Risperdal maker hit with $1.1 billion verdict

The state attorney general argued that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, illegally marketed the drug by telling doctors it was safer and more effective than competitor drugs, downplayed its risks and marketed it for unapproved uses including treatment for the elderly and children.

Leave a Reply

Your email address will not be published. Required fields are marked *

*